ReviewAbdominal radiology (New York)2025
Cystic genitourinary lesions in the pelvis: pearls and pitfalls.
Review in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Urachal inflammatory myofibroblastic tumor: a case report.Frontiers in oncology · 2026Article
- A giant complex pelvic cystic lesion misdiagnosed as a seminal vesicle tumor: A rare case report of prostatic cyst.Urology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic lesions of the genitourinary (GU) tract in the pelvis represent a diverse group of entities that can be challenging to characterize due to overlapping anatomy and variable imaging appearances. While most lesions are benign, accurate identification is critical to guide appropriate clinical management and avoid misdiagnosis. This review presents a comprehensive, image-rich overview of cystic pelvic lesions, focusing on the anterior and middle compartments in both male and female patients. Imaging modalities such as ultrasound, CT, and MRI each provide distinct advantages depending on the clinical context and lesion characteristics. Key entities include bladder, urethral, and ureteral diverticula; urachal anomalies; prostatic utricle and Müllerian duct cysts; seminal vesicle and ejaculatory duct cysts; Gartner duct and Bartholin gland cysts; and infectious processes. Less common pathologies, such as lymphangiomas, benign cystic tumors, and mimics of cystic lesions, including bulking agents, hydrogel spacers, hernias, and cystic degeneration of solid tumors, are also addressed. This manuscript offers practical pearls and highlights potential pitfalls in the evaluation of cystic GU lesions. Familiarity with typical imaging features and potential mimics is essential to ensure diagnostic accuracy and improve patient outcomes.
Indexed as
Identifiers
40459596What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.